Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study
C. Lhommé, S. Pecorelli(Mylan (Switzerland)), Adam Pawinski, Ana Alvarez(Hospital Clínico San Carlos), C. Mendiola(Hospital Universitario 12 De Octubre), Jan B. Vermorken(University of Antwerp), M.A. Lentz, Bernard Chevalier(University of Zurich), E. Mickiewicz(University of Chicago)
Cited by 43
Related Papers
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
|The Lancet|2007|912
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
|New England Journal of Medicine|2021|571
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis
|Journal of the American College of Cardiology|2017|486